Staar Surgical STAA
$25.21 −$1.51 (-5.65%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $24.72 -1.94%
Open$26.41
Prev close$26.72
Day range$25.06 – $26.70
Volume1.04M
Market cap$1.27B
P/E (TTM)2,521.0
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Jul 2026
Revenue$93.54M+111.0% YoY
Operating profit$10.10M+140.9% YoY
Net profit$8.06M+147.9% YoY
Diluted EPS$0.16+147.1% YoY
Free cash flow$19.20M+166.1% YoY
Operating cash flow$19.69M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin76.6%
Operating margin12.1%
Net margin1.1%
Return on equity1.1%
Return on assets0.8%
Return on invested capital0.4%
Current ratio4.66
Liabilities / assets23.1%
Cash & investments$181.49M
Total debt$29.77M
Net cash (debt)$151.72M
Income statement
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $93.54M | $93.52M | $239.44M | $57.80M | $94.73M |
| Total Operating Revenue | $93.54M | $93.52M | $239.44M | $57.80M | $94.73M |
| Cost of Revenue | $23.81M | $24.66M | $57.02M | $14.06M | $16.86M |
| Gross Profit | $69.73M | $68.86M | $182.42M | $43.74M | $77.88M |
| Operating Expense | $59.63M | $51.46M | $228.37M | $54.68M | $53.43M |
| Selling and Admin Expenses | $49.68M | $41.53M | $188.31M | $45.43M | $44.22M |
| -Selling & Marketing Expense | $26.94M | $24.51M | $102.53M | $25.84M | $23.46M |
| -General & Admin Expense | $22.74M | $17.02M | $85.78M | $19.59M | $20.76M |
| Research & Development | $9.94M | $9.93M | $40.06M | $9.24M | $9.21M |
| Operating Profit | $10.10M | $17.40M | -$45.95M | -$10.94M | $24.44M |
| Net Non-Operating Interest Income (Expense) | $939,000.00 | $907,000.00 | $4.59M | $1.07M | $790,000.00 |
| Non-Operating Interest Income | $939,000.00 | – | $4.59M | $1.07M | $790,000.00 |
| Other Income (Expense) | -$16,000.00 | -$10.09M | -$40.91M | -$10.79M | -$6.44M |
| Gain on Sale of Security | -$410,000.00 | -$1.11M | $2.60M | -$535,000.00 | -$843,000.00 |
| Special Income (Charges) | $0.00 | -$9.42M | -$45.77M | -$11.90M | -$5.95M |
| -Less:Restructuring and Mergern & Acquisition | $0.00 | $9.42M | $45.77M | $26.50M | $5.95M |
| Other Non-Operating Income (Expenses) | $394,000.00 | $443,000.00 | $2.25M | $1.65M | $353,000.00 |
| Pretax Profit | $11.02M | $8.22M | -$82.26M | -$20.65M | $18.79M |
| Tax | $2.97M | $3.01M | -$1.82M | -$2.34M | $9.91M |
| Net Profit | $8.06M | $5.21M | -$80.45M | -$18.31M | $8.88M |
| Profit from Continuing Operations | $8.06M | $5.21M | -$80.45M | -$18.31M | $8.88M |
| Net Income to Parent Company | $8.06M | $5.21M | -$80.45M | -$18.31M | $8.88M |
| Net Income to Common Stockholders | $8.06M | $5.21M | -$80.45M | -$18.31M | $8.88M |
| Basic EPS | $0.16 | $0.10 | -$1.62 | -$0.37 | $0.18 |
| Diluted EPS | $0.16 | $0.10 | -$1.62 | -$0.37 | $0.18 |
| Total Other Finance Costs | – | -$907,000.00 | – | – | – |
| -Less:Impairment of Capital Assets | – | – | – | – | $0.00 |
Balance sheet
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $475.21M | $451.12M | $451.68M | $451.68M | $456.36M |
| Total Current Assets | $342.35M | $312.40M | $311.55M | $311.55M | $321.21M |
| Cash and Cash Equivalents & Short-Term Investments | $181.49M | $163.89M | $187.54M | $187.54M | $192.66M |
| -Cash and Cash Equivalents | $148.58M | $131.86M | $153.15M | $153.15M | $176.16M |
| -Short Term Investments | $32.91M | $32.03M | $34.39M | $34.39M | $16.51M |
| Receivables | $102.06M | $85.69M | $54.31M | $54.31M | $63.57M |
| -Accounts Receivable | $98.48M | $81.17M | $50.06M | $50.06M | $60.11M |
| -Taxes Receivable | $3.58M | $4.52M | $4.24M | $4.24M | $3.46M |
| Prepaid Assets | $7.97M | $12.18M | $13.83M | $13.83M | $9.57M |
| Inventory | $46.84M | $49.78M | $55.50M | $55.50M | $53.30M |
| Other Current Assets | $4.00M | $851,000.00 | $374,000.00 | $374,000.00 | $2.11M |
| Total Non-Current Assets | $132.85M | $138.72M | $140.13M | $140.13M | $135.15M |
| Net PPE | $97.44M | $100.31M | $102.93M | $102.93M | $103.94M |
| -Gross PPE | $153.60M | $153.59M | $153.90M | $153.90M | $157.21M |
| -Accumulated Depreciation | -$56.17M | -$53.28M | -$50.97M | -$50.97M | -$53.27M |
| Goodwill and Other Intangible Assets | $33.10M | $36.05M | $32.49M | $32.49M | $1.79M |
| -Goodwill | $1.79M | $1.79M | $1.79M | $1.79M | $1.79M |
| -Other Intangible Assets | $31.32M | $34.27M | $30.70M | $30.70M | – |
| Non-Current Deferred Assets | $1.09M | $1.09M | $3.37M | $3.37M | $1.98M |
| Other Non-Current Assets | $1.23M | $1.27M | $1.35M | $1.35M | $27.45M |
| Total Liabilities | $109.81M | $98.75M | $107.49M | $107.49M | $102.58M |
| Total Current Liabilities | $73.39M | $60.99M | $68.50M | $68.50M | $61.64M |
| Payables | $16.88M | $10.42M | $13.77M | $13.77M | $12.02M |
| -Accounts Payable | $13.48M | $8.70M | $11.57M | $11.57M | $9.18M |
| -Total Tax Payable | $2.14M | – | $1.30M | $1.30M | $1.08M |
| -Other Payable | $1.26M | $1.73M | $894,000.00 | $894,000.00 | $1.76M |
| Current Accrued Expenses | $14.88M | $11.51M | $14.66M | $14.66M | $13.60M |
| Short-Term Debt and Capital Lease Obligation | $6.18M | $6.10M | $5.87M | $5.87M | $5.31M |
| -Current Capital Lease Obligation | $6.18M | $6.10M | $5.87M | $5.87M | $5.31M |
| Other Current Liabilities | $31.59M | $29.05M | $24.77M | $24.77M | $22.55M |
| Total Non-Current Liabilities | $36.41M | $37.76M | $38.99M | $38.99M | $40.95M |
| Long Term Debt and Capital Lease Obligation | $29.77M | $31.19M | $32.48M | $32.48M | $33.80M |
| -Long Term Capital Lease Obligation | $29.77M | $31.19M | $32.48M | $32.48M | $33.80M |
| Non-Current Liabilities | $44,000.00 | $44,000.00 | $45,000.00 | $45,000.00 | $43,000.00 |
| Non-Current Deferred Liabilities | $89,000.00 | $89,000.00 | $89,000.00 | $89,000.00 | $89,000.00 |
| Employee Benefits | $6.52M | $6.44M | $6.38M | $6.38M | $7.01M |
| Total Equity | $365.40M | $352.37M | $344.18M | $344.18M | $353.78M |
| Stockholders' Equity | $365.40M | $352.37M | $344.18M | $344.18M | $353.78M |
| Capital Stock | $505,000.00 | $502,000.00 | $498,000.00 | $498,000.00 | $497,000.00 |
| -Common Stock | $505,000.00 | $502,000.00 | $498,000.00 | $498,000.00 | $497,000.00 |
| Additional Paid-In Capital | $513.08M | $507.92M | $504.68M | $504.68M | $495.99M |
| Retained Earnings | -$134.76M | -$142.82M | -$148.02M | -$148.02M | -$129.72M |
| Less: Treasury Stock | $6.46M | $6.46M | $6.46M | $6.46M | $6.46M |
| Gains/Losses Not Affecting Retained Earnings | -$6.97M | -$6.78M | -$6.51M | -$6.51M | -$6.53M |
Cash flow
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $19.69M | -$21.70M | -$34.23M | -$3.91M | $2.67M |
| Net cash flow from continuing operations | $19.69M | -$21.70M | -$34.23M | -$3.91M | $2.67M |
| Net Income from Continuing Operations | $8.06M | $5.21M | -$80.45M | -$18.31M | $8.88M |
| Gain/Loss from Continuing Operations | $17,000.00 | $31,000.00 | -$1.63M | -$1.70M | $68,000.00 |
| Depreciation & Depletion & Amortization | $3.34M | $2.21M | $8.73M | $2.42M | $1.80M |
| Deferred Tax | $324,000.00 | $2.81M | -$2.92M | -$2.20M | $9.91M |
| Other Non-Cash Items | $916,000.00 | $857,000.00 | $3.57M | $909,000.00 | $799,000.00 |
| Change in Working Capital | -$2.68M | -$42.69M | -$16.33M | $924,000.00 | -$30.59M |
| -Change in Receivables | -$17.31M | -$31.92M | $27.83M | $9.83M | -$25.86M |
| -Change in Inventory | $2.75M | $4.09M | -$16.98M | -$4.53M | -$1.24M |
| -Change in Prepaid Assets | $5.09M | $353,000.00 | -$1.35M | $8.36M | -$10.35M |
| -Change in Payables and Accrued Expense | $4.69M | -$2.96M | -$5.51M | $2.40M | -$2.49M |
| -Change in Other Current Assets | -$1.38M | -$3.67M | -$15.76M | – | – |
| -Change in Other Current Liabilities | $3.47M | -$8.58M | -$4.56M | $629,000.00 | $2.24M |
| Net cash flow from investing | -$1.37M | $2.15M | $46.34M | -$19.42M | $5.28M |
| Net Cash Flow from Continuing Investing Activities | -$1.37M | $2.15M | $46.34M | -$19.42M | $5.28M |
| Net PPE Purchase and Sale | -$494,000.00 | -$443,000.00 | -$5.82M | -$1.68M | -$883,000.00 |
| Net Investment Purchase and Sale | -$872,000.00 | $2.59M | $52.16M | -$17.74M | $6.17M |
| Financing Cash Flow | -$1.50M | -$1.69M | -$4.56M | -$50,000.00 | $983,000.00 |
| Net Cash Flow from Continuing Financing Activities | -$1.50M | -$1.69M | -$4.56M | -$50,000.00 | $983,000.00 |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | -$42,000.00 | $0.00 | $0.00 |
| Net Common Stock Issuance | -$2.73M | -$1.87M | -$7.98M | -$164,000.00 | -$1.98M |
| Proceeds from Stock Option Exercised | $1.23M | $174,000.00 | $3.47M | $114,000.00 | $2.96M |
| Ending Cash Balance | $148.58M | $131.86M | $153.15M | $153.15M | $176.16M |
| Net Change in Cash | $16.82M | -$21.24M | $7.55M | -$23.38M | $8.93M |
| Beginning Cash Balance | $131.86M | $153.15M | $144.16M | $176.16M | $167.13M |
| Effect of Exchange Rate Changes | -$107,000.00 | -$45,000.00 | $1.44M | $374,000.00 | $91,000.00 |
| Free Cash Flow | $19.20M | -$22.14M | -$40.05M | -$5.59M | $1.78M |
No comments yet — be the first to weigh in on STAA.
Sign in to join the discussion.